Sun Pharmaceutical Industries Ltd. is a leading pharmaceutical company based in India. With an ESG score of 31.5, it is categorized as high risk. Specializing in generic drugs, it is the fourth largest pharmaceutical manufacturer globally. Sun Pharma serves its largest markets in the U.S. and India while also expanding its reach to emerging and developed markets. In addition to generics, the company distributes name-brand formulas in specific regions. With manufacturing and research facilities worldwide, Sun Pharma's primary operations are in India.